MedWatch

Scandion Oncology will develop existing drug to revert resistance

An approved drug may be able to revert anti-cancer drug resistance. Danish Scandion Oncology and researchers from University of Copenhagen and will now initiate development of the drug.

Foto: /Ritzau Scanpix/Morten Dueholm

The next breakthrough in cancer treatment might already be available in the pharmacies.

According to Danish biotech firm Scandion Oncology, an unidentified approved drug can potentially revert drug resistance in cancer patients and thus enable them continue their treatment.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier